Janus Henderson Group PLC Agios Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 25,897 shares of AGIO stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,897

Previous 29,581 12.45%

Holding current value

$1.52 Million

Previous $864,000 29.17%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $101,494 - $179,889	-3,684 Reduced 12.45%	25,897 $1.12 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $149 - $243	7 Added 0.02%	29,581 $864,000
Q4 2023 Feb 14, 2024	SELL	$19.97 - $24.53 $818 - $1,005	-41 Reduced 0.14%	29,574 $658,000
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $73 - $84	3 Added 0.01%	29,615 $732,000
Q2 2023 Aug 14, 2023	SELL	$21.38 - $29.19 $748 - $1,021	-35 Reduced 0.12%	29,612 $838,000
Q1 2023 May 15, 2023	BUY	$21.74 - $30.93 $457,800 - $651,323	21,058 Added 245.17%	29,647 $680,000
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $213,093 - $270,725	8,589 New	8,589 $241,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $167,571 - $293,228	8,589 New	8,589 $243,000
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $146,443 - $269,709	-8,584 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $109,654 - $143,069	-4,110 Reduced 32.38%	8,584 $250,000
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $188,542 - $317,297	6,374 Added 100.85%	12,694 $418,000
Q3 2021 Nov 16, 2021	BUY	$41.92 - $58.18 $264,934 - $367,697	6,320 New	6,320 $292,000
Q4 2018 Feb 06, 2019	SELL	$42.73 - $76.53 $1.06 Million - $1.9 Million	-24,800 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$71.67 - $91.95 $544,692 - $698,820	-7,600 Reduced 23.46%	24,800 $1.91 Million
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $541,828 - $736,670	7,400 Added 29.6%	32,400 $2.73 Million
Q1 2018 May 14, 2018	SELL	$59.83 - $86.53 $27.5 Million - $39.8 Million	-460,239 Reduced 94.85%	25,000 $2.05 Million
Q4 2017 Feb 09, 2018	BUY	$52.12 - $72.33 $5.04 Million - $6.99 Million	96,703 Added 24.89%	485,239 $27.7 Million
Q3 2017 Nov 14, 2017	SELL	$54.89 - $67.12 $462,064 - $565,016	-8,418 Reduced 2.12%	388,536 $0
Q2 2017 Aug 17, 2017	BUY	N/A	396,954	396,954 $20.4 Million

Others Institutions Holding AGIO

# of Institutions

230

Shares Held

55.4M

Call Options Held

301K

Put Options Held

254K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.21B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Agios Pharmaceuticals, Inc. Transaction History